Want to join the conversation?
Drugs major $BMY said global sales of Eliquis grew 78% YoverY as the company continued to make progress towards the goal of becoming the number 1 novel anticoagulant. In the US, 2Q16 continued the trend of strong Eliquis performance. Also, during the quarter, the company saw strong sales performance for Opdivo and Yervoy.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.